Press Releases from Halsin Partners (6 total)
Transimmune Secures $5m Funding to Enhance mRNA Vaccination with Novel Dendritic …
• Expansion of existing Bill & Melinda Gates Foundation relationship aims to design mRNA guided therapies that more directly mirror the natural immune system response to…
NETRIS Pharma led consortium awarded €1.2 million Eurostar grant to explore ne …
ACTaNet project will focus on chronic bone pain in arthritis and cancer initially leveraging anti-netrin-1 antibody NP137
January 19, 2023
Lyon, Copenhagen and Stockholm - NETRIS…
Allelica’s Polygenic Risk Score Published in Circulation Identifies People at …
Rome, Italy, March 8, 2021 – Allelica, a leading genomics software company specialising in developing polygenic risk scores (PRS) for personalised medicine, today announced publication…
OHMX.bio and Fujirebio Europe Receive Grant of 720K EURO to Incorporate Third Ge …
Ghent, Belgium, December 8, 2020 – OHMX.bio, a provider of cutting-edge “omics” solutions, and Fujirebio Europe announced today that they have been awarded a 720K…
Neem Biotech Presents Data Showing Effectiveness of the Quorum Sensing Inhibitor …
Ajoene found to reduce virulence factor secretion, destabilise mature bacterial biofilms, allowing re-sensitisation to antibacterial agents
Neem Evaluating Drug Candidates based on Ajoene for Clinical Evaluation…
Neem Biotech, Welsh Wound Innovation Centre and Sheffield Collaboratorium for An …
National Biofilms Innovation Centre’s (NBIC) £50,000 Grant to Expand Knowledge on Novel Anti-Biofilm Clinical Drug Candidates
Cardiff, UK|14.12.2018
Neem Biotech, a company focused on developing novel solutions…
Go To Page:
